• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

PF-4708671

CAS No. 1255517-76-0

PF-4708671 ( PF4708671 | PF-4708671 | PF 4708671 )

产品货号. M11039 CAS No. 1255517-76-0

PF-4708671 是一种 p70 核糖体 S6 激酶(S6K1 亚型)的细胞渗透性抑制剂,在无细胞测定中 Ki/IC50 为 20 nM/160 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥381 有现货
10MG ¥567 有现货
25MG ¥915 有现货
50MG ¥1239 有现货
100MG ¥2260 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    PF-4708671
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    PF-4708671 是一种 p70 核糖体 S6 激酶(S6K1 亚型)的细胞渗透性抑制剂,在无细胞测定中 Ki/IC50 为 20 nM/160 nM。
  • 产品描述
    PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) with Ki/IC50 of 20 nM/160 nM in cell-free assays, 400-fold greater selectivity for S6K1 than S6K2, and 4- and >20-fold selectivity for S6K1 than MSK1 and RSK1/2, respectively. First S6K1-specific inhibitor to be reported.
  • 体外实验
    PF-4708671 inhibits the activity of full-length S6K1 in vitro with a Ki of 20 nM, and S6K1 isolated from IGF1-stimulated HEK293 cells with an IC50 of 0.16 μM, and only inhibits very weakly the closely related S6K2 isoform (IC50 of 65 μM). PF-4708671 inhibits RSK1 (IC50 of 4.7 μM) and RSK2 (IC50 of 9.2 μM) over 20-fold less potently than S6K1. PF4708671 inhibits MSK1 (IC50 of 0.95 μM) 4-fold more weakly than S6K1. HCT116 cells are treated with (i) vehicle (DMSO), (ii) OSI-906 (5 μM), (iii) PF-4708671 (10 μM), and (iv) OSI-906 (5 μM)+PF-4708671 (10 μM) for various amounts of time. HCT116 cells treated with OSI-906 alone (closed square) or PF4708671 alone (open circle) slightly inhibit cell growth. In contrast, proliferation in HCT116 cells is significantly inhibited after a 2-day treatment with the combination of OSI-906 and PF-4708671 (closed circle). A similar result is also observed when SW480 cells are treated with the combination of OSI-906 and PF-4708671. Colony formation also significantly reduces in OSI-906+PF-4708671-treated cells comparing with vehicle, OSI-906 alone, or PF-4708671 alone treated HCT116 or SW480 cells.
  • 体内实验
    The tumor growth rate in mice treated with the combination of OSI-906+PF-4708671 is significantly slower than that of OSI-906 alone (P=0.0189) or PF4708671 alone (P=0.0165) treated mice. The average tumor volume in the OSI-906+PF-4708671-treated mice is approximately 50% of that in mice treated with OSI-906 (P=0.0056) or PF-4708671 alone (P<0.001) at the end of a 15-day treatment.
  • 同义词
    PF4708671 | PF-4708671 | PF 4708671
  • 通路
    PI3K/Akt/mTOR signaling
  • 靶点
    S6 Kinase
  • 受体
    p70 S6K
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    1255517-76-0
  • 分子量
    390.41
  • 分子式
    C19H21F3N6
  • 纯度
    >98% (HPLC)
  • 溶解度
    Ethanol: 8 mg/mL (20.49 mM); DMSO: 30 mg/mL (76.84 mM)
  • SMILES
    FC(C1=CC=C2NC(CN3CCN(C4=NC=NC=C4CC)CC3)=NC2=C1)(F)F
  • 化学全称
    2-((4-(5-ethylpyrimidin-4-yl)piperazin-1-yl)methyl)-5-(trifluoromethyl)-1H-benzo[d]imidazole

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Pearce LR, et al. Biochem J, 2010, 431(2), 245-255.
产品手册
关联产品
  • PF-4708671

    PF-4708671 是一种 p70 核糖体 S6 激酶(S6K1 亚型)的细胞渗透性抑制剂,在无细胞测定中 Ki/IC50 为 20 nM/160 nM。

  • FMK

    FMK 是一种不可逆的 RSK2 抑制剂,能够共价修饰 RSK 的 C 末端区域。

  • MBM-55S

    MBM-55S 通过诱导细胞周期停滞和细胞凋亡来有效抑制癌细胞的增殖。 MBM-55S具有抗肿瘤活性,且对小鼠无明显毒性。